Broughton's Director of Product Development Services, Dr Fozia Saleem, and Technical Sales Administrator, Curtis Gallagher collaborates with leading global pharmaceutical experts at the Drug Delivery to the Lungs (DDL) Conference.
The Drug Delivery to the Lungs (DDL) virtual Conference is the premier international conference covering all aspects of respiratory drug delivery and recent developments in the field of inhalation therapy. For the past 30 years, DDL has attracted global industry experts dedicated to advancing pulmonary and nasal drug delivery. For more information on the event, click here.
At Broughton, we understand first-hand how challenging it can be to take a product from concept through to global launch. To address this we have assembled a team of product development, scientific substantiation, and regulatory experts to guide you through your entire product development and regulatory submission journey.
Director of Product Development Services, Dr Fozia Saleem, and Technical Sales Administrator, Curtis Gallagher will be attending this industry-leading event and would be delighted to meet with existing and new clients. If you would like to discuss what’s happening in the industry and to find out how Broughton can help clients in meeting their regulatory obligations while bringing life-enhancing products to market, we would be delighted to speak to you.
DDL takes place on 8-10th December 2021 – online.
To find out more contact us to arrange a meeting.
Can we help you?
Broughton have deep CRO capabilities and an experienced team of scientific and regulatory professionals to manage full service global regulatory projects. Our knowledge of global regulatory pathways offers significant insights that can be incorporated into your project plans. Our mission is to accelerate safer nicotine-delivery products to market; creating a smoke-free future.
Book a meeting with us today to discuss your requirements.